Le Lézard
Classified in: Health
Subject: MAT

Kadenwood, LLC, Launches All-Natural Melatonin Infused CBD Oil Drops


NEWPORT BEACH, Calif, June 17, 2020 /PRNewswire/ -- Kadenwood, LLC, a consumer seed-to-shelf CBD company dedicated to fostering trust and transparency in the mainstream wellness category, announced today the launch of Level Zzz CBD Oil Drops, an all-natural Melatonin-infused CBD oil. The new addition to the growing portfolio of performance-based personal care products under the LEVEL SELECTtm brand, was developed in response to consumers' calls requesting a product aimed at helping users achieve restful sleep using the trusted and pure CBD formula.

Made with all-natural ingredients, Level Zzz CBD Oil Drops brings users the calming benefits of CBD with the sleep encouraging properties of Melatonin to help relieve sleeplessness. It features Kadenwood's propriety blend of Broad Spectrum CBD, with 40mg of CBD and 3mg of Melatonin per dose in a soothing vanilla flavor.

The new offering joins the existing LEVEL SELECTTM lineup of topical CBD Roll-Ons, Sports Creams and Oil Drops, all containing only the purest form of CBD oil, with 0% THC (tetrahydrocannabinol), created through Kadenwood's unique vertically-integrated seed-to-shelf production technology.

"While we pride ourselves on keeping our own commitment to maintaining industry leading standards across quality and potency, we also have a commitment to listen to our consumers and respond to their needs," says Traci Mason, Vice President and General Manager at Kadenwood. "We've received so many calls from fans of our products asking for a sleep-focused offering, so we developed Level Zzz with our quality standards and their requests in mind."

"We've truly raised the bar with Level Zzz, perfecting the formula to offer our users just the right blend of CBD and Melatonin to help them unwind and achieve restful sleep, both of which can be hard to come by during these times of uncertainty," says Erick Dickens, CEO and co-founder of Kadenwood, "This product is a game-changer because it helps calm both the body and mind. We are proud to be able to quickly innovate and respond to our consumers' needs with products of exceptional quality."

Designed to lead the way for high-quality personal care CBD products, the LEVEL SELECTtm brand offers a portfolio of performance-based CBD products helping users maintain a healthy and active lifestyle from smaller everyday activities to physical exercise, competitive sports, travel and more. Kadenwood is backed by a team of experts including former Surgeon General Richard Carmona, MD, MPH, FACS who sits on the Advisory Board and provides insights into best practices, from guiding internal practices to technological innovations. Kadenwood's proprietary CBD is developed to the highest standards across quality and potency and controlled through owned farm and agriculture facilities that are setting a new industry standard for CBD production.

LEVEL SELECTtm Level Zzz Oil Drops are now available online at LevelSelectCBD.com for $99.99.

About CBD
CBD is a non-intoxicating cannabinoid found in cannabis. After tetrahydrocannabinol (THC), cannabidiol (CBD) is the second most abundant cannabinoid in the plant and is believed to have many potential therapeutic benefits, including anti-inflammatory, analgesic, anti-anxiety and seizure-suppressant properties.

About Kadenwood, LLC
Founded in 2019, Kadenwood is a privately-held consumer products lifestyle company relentlessly focused on shaping CBD into a trusted and safe mainstream wellness category. To drive this mission, Kadenwood is backed by decades of CPG marketing and category innovation expertise and industry-leading, vertically-integrated CBD farming to ensure quality CBD oil from seed-to-shelf that contains no THC. In Fall 2019, Kadenwood launched its first branded products under LEVEL SELECTtm in personal care.

To learn more about Kadenwood and follow news about its farms and soon-to-launch branded products, please visit http://www.kadenwoodbrands.com.

SOURCE Kadenwood, LLC


These press releases may also interest you

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...

at 18:15
Equality Health Foundation, the philanthropic partner of Equality Health LLC and an organization dedicated to advancing health equity and improving well-being access for underserved communities, proudly announces its expansion into Virginia and...

at 18:01
Aflac Incorporated announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid...



News published on and distributed by: